Iridex Corp
IRIXNasdaqCIK 1006045HealthcareFiscal year ends Jan 3
Reports and events: 309 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-0220:20 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001193125-26-380229 |
| 2026-08-1820:54 ET | 10-Q | Quarterly reportPeriod 2026-07-04 | 0001193125-26-355641 |
| 2026-08-1820:51 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-355635 |
| 2026-07-1610:01 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-305344 |
| 2026-07-1321:49 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0002064835-26-000078 |
| 2026-06-1820:14 ET | 8-K | 8.01 Other events | 0001193125-26-275883 |
| 2026-05-1920:16 ET | 10-Q | Quarterly reportPeriod 2026-04-04 | 0001193125-26-230789 |
| 2026-05-1920:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-230774 |
| 2026-04-2420:05 ET | DEF 14A | Proxy statementPeriod 2026-06-12 | 0002077096-26-000092 |
| 2026-04-0220:20 ET | 10-K | Annual reportPeriod 2026-01-03 | 0001193125-26-140194 |
| 2026-03-2620:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-126323 |
| 2026-03-1320:16 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-106190 |
| 2026-01-1214:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-009912 |
| 2026-01-0821:28 ET | SCHEDULE 13D | Ownership report, active investor | 0002097627-26-000007 |
| 2025-12-1115:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-315298 |
| 2025-11-1221:25 ET | 10-Q | Quarterly reportPeriod 2025-09-27 | 0001193125-25-277712 |
| 2025-11-1221:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-277598 |
| 2025-09-0920:22 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-199190 |
| 2025-08-1220:28 ET | 10-Q | Quarterly reportPeriod 2025-06-28 | 0000950170-25-107375 |
| 2025-08-1220:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-107345 |
| 2025-06-1320:38 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-086292 |
| 2025-05-2220:18 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-076352 |
| 2025-05-2021:26 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001174947-25-000809 |
| 2025-05-1320:43 ET | 10-Q | Quarterly reportPeriod 2025-03-29 | 0000950170-25-070469 |
| 2025-05-1320:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-070385 |
| 2025-04-2820:11 ET | DEF 14A | Proxy statementPeriod 2025-06-11 | 0001174947-25-000633 |
| 2025-04-1420:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-053714 |
| 2025-04-0820:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-075760 |
| 2025-04-0321:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-072447 |
| 2025-03-2720:24 ET | 10-K | Annual reportPeriod 2024-12-28 | 0000950170-25-046107 |
| 2025-03-2720:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-046076 |
| 2025-03-2021:39 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-042190 |
| 2025-01-1418:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-005194 |
| 2024-11-2600:16 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0000950170-24-130699 |
| 2024-11-2600:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-130698 |
| 2024-11-1322:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-126507 |
| 2024-11-1221:35 ET | 10-Q | Quarterly reportPeriod 2024-09-28 | 0000950170-24-125541 |
| 2024-11-1221:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-125464 |
| 2024-10-0321:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-112474 |
| 2024-09-0610:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-104222 |
| 2024-08-0820:31 ET | 10-Q | Quarterly reportPeriod 2024-06-29 | 0000950170-24-094090 |
| 2024-08-0820:11 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-093966 |
| 2024-08-0513:25 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-090371 |
| 2024-07-0320:16 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001193125-24-175053 |
| 2024-06-2121:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000950170-24-075755 |
| 2024-05-2420:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-064595 |
| 2024-05-1421:07 ET | 10-Q | Quarterly reportPeriod 2024-03-30 | 0000950170-24-059771 |
| 2024-05-1420:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-059624 |
| 2024-04-2921:01 ET | DEF 14A | Proxy statementPeriod 2024-06-18 | 0001174947-24-000612 |
| 2024-03-2920:13 ET | 10-K | Annual reportPeriod 2023-12-30 | 0000950170-24-038650 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.